Key result
Increased frailty linked to ~48% higher mortality and 30-day readmission odds in head and neck cancer.
Why the study?
To understand preoperative measures of frailty and evaluate how they predict perioperative outcomes in patients with head and neck cancer.
Does frailty predict perioperative outcomes in patients with head and neck cancer?
Cross-Sectional (n=410)
No
Does frailty predict perioperative outcomes in patients with head and neck cancer?
Odds Ratio: 1.475
p-value: p=0.012
The modified frailty index is a significant predictor of poor perioperative outcomes and mortality in patients undergoing surgery for head and neck cancer.
May support preoperative frailty screening in head and neck cancer surgery; leaves open whether modification improves outcomes.
OBJECTIVES: To understand measures of frailty among preoperative patients and explain how these can predict perioperative outcomes among patients with head and neck cancer. STUDY DESIGN: Retrospective cross-sectional case series with chart review. SETTING: Academic tertiary medical center. SUBJECTS AND METHODS: A retrospective review was performed of patients presenting to an academic hospital following a surgical procedure for a head and neck cancer diagnosis. Charts were queried for preoperative medical diagnoses to calculate 2 frailty scores: the American College of Surgeons National Surgical Quality Improvement Program modified frailty index and the Johns Hopkins Adjusted Clinical Groups frailty index. The American Society of Anesthesiologists classification system was also analyzed as a predictor. Primary outcomes were mortality, 30-day readmission, and length of stay. Perioperative complications and discharge disposition were also evaluated. RESULTS: A total of 410 charts were queried between January 2014 and December 2017. Mortality was 11%; mean ± SD length of stay was 7.4 ± 5.5 days; and the readmission rate was 17%. The modified frailty index score significantly increased the odds of mortality (odds ratio = 1.475, P = .012) and readmission (odds ratio = 1.472, P = .004), the length of stay (relative risk = 1.136, P = .001), and the number of perioperative complications. The American Society of Anesthesiologists classification was also significantly associated with poor outcomes, including readmission, length of stay, and perioperative complications. The Adjusted Clinical Groups index was not a significant predictor of outcomes in this study population. CONCLUSIONS: This study demonstrated a significant increase in poor perioperative outcomes and mortality among patients with head and neck cancer and increased frailty, as measured by the modified frailty index.
No takes yet. Share an insight, caveat, or question.
Pitts et al. (2019) conducted a cross-sectional in Head and neck cancer (n=410). Frailty (modified frailty index) was evaluated on Mortality (OR 1.475, p=0.012). Increased frailty, measured by the modified frailty index, significantly increased the odds of mortality (OR 1.475, P=0.012) and 30-day readmission (OR 1.472, P=0.004) in head and neck cancer patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: